Copyright
©The Author(s) 2017.
World J Gastroenterol. Oct 14, 2017; 23(38): 6983-6994
Published online Oct 14, 2017. doi: 10.3748/wjg.v23.i38.6983
Published online Oct 14, 2017. doi: 10.3748/wjg.v23.i38.6983
Figure 6 The changes of ammonia levels and inflammatory cytokines in plasma from the portal or tail veins.
A: Plasma ammonia levels decreased significantly upon FMT treatment. Blood samples were collected from the portal and tail veins in the indicated groups and analyzed with an automatic biochemistry analyzer; B: Decreased circulating IL-1β was observed in the FMT groups. Blood samples were collected from the portal and tail veins in the indicated groups and analyzed by ELISA; C: Serum IL-6 was reduced in the FMT-treated groups. Blood samples were collected from the portal and tail veins in the indicated groups and analyzed by ELISA; D: Serum TNF-α was downregulated in the FMT-treated groups. Blood samples were collected from the portal and tail veins in the indicated groups and analyzed by ELISA. FMT: Fecal microbiota transplantation.
- Citation: Wang WW, Zhang Y, Huang XB, You N, Zheng L, Li J. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. World J Gastroenterol 2017; 23(38): 6983-6994
- URL: https://www.wjgnet.com/1007-9327/full/v23/i38/6983.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i38.6983